GlassScriptPhysician profile
Syed Khalid Husain
NPI 1821182361
$82,134.84
in general payments reported to CMS, 2019-2025
42 companies · $1,253 in 2025
The $1,253 reported for 2025 was more than what 84% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,971 · 2020: $41K · 2021: $8,937 · 2022: $813 · 2023: $23K · 2024: $1,243 · 2025: $1,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $6,277 · Food and Beverage: $2,597 · Education: $2,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,141.08 |
| Travel and Lodging | $6,277.18 |
| Food and Beverage | $2,597.27 |
| Education | $2,231.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $63,149.05 | 2020-2023 | Restrata Wound Matrix |
| Kerecis Limited | $8,030.33 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Melinta Therapeutics, LLC | $4,228.56 | 2019-2022 | |
| Stryker Corporation | $1,424.68 | 2019-2024 | Prostep, Prostep Mica |
| Smith+Nephew, INC. | $1,046.52 | 2019-2025 | Grafix Pl, Oasis, Stravix Pl |
| Organogenesis INC. | $1,018.11 | 2019-2025 | Puraply, Affinity, Apligraf |
| Paratek Pharmaceuticals, INC. | $540.04 | 2021-2025 | Nuzyra |
| Biotissue Holdings INC. | $453.41 | 2019-2021 | |
| Mimedx Group, INC. | $379.78 | 2024-2025 | |
| Amgen INC. | $281.84 | 2024-2025 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $229.70 | 2019-2021 | |
| Horizon Therapeutics Plc | $183.82 | 2019-2023 | Krystexxa |
| Orthofix Medical, INC. | $125.72 | 2021-2025 | Physio-Stim |
| Kci USA, INC. | $117.27 | 2019-2022 | |
| Osiris Therapeutics INC. | $104.94 | 2019 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $77.39 | 2020-2022 | |
| Paragon 28, INC. | $70.57 | 2024-2025 | Ttc Nail, Bun-Yo-Matic |
| Aroa Biosurgery Incorporated | $61.07 | 2022-2024 | |
| Next Science LLC | $46.11 | 2023-2024 | Blastx, Xperience, Surgx |
| Depuy Synthes Sales INC. | $38.77 | 2023 | Na, Motoband |
| Lifenet Health | $38.59 | 2025 | Theragenesis Wound Matrix |
| Bioventus LLC | $37.56 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Djo, LLC | $31.08 | 2024 | Cmf |
| Biowound Solutions, INC. | $30.59 | 2025 | Bio-Connekt |
| Ets Wound Care LLC | $30.33 | 2025 | Mirragen Advanced Wound Matrix |
| Axogen | $29.41 | 2025 | Axoguard Nerve Cap |
| Cashflow Solutions, LLC | $28.99 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Fusion Orthopedics USA, LLC | $26.97 | 2025 | |
| Misonix INC | $24.90 | 2019 | |
| Polarityte, INC. | $23.79 | 2019 | |
| Fidia Pharma USA INC. | $23.67 | 2019-2020 | |
| Convatec INC. | $22.85 | 2023 | |
| Abbvie INC. | $22.39 | 2019 | |
| Grt US Holding, INC. | $22.38 | 2022 | |
| Averitas Pharma INC. | $20.92 | 2023 | Qutenza |
| Medtronic, INC. | $20.86 | 2023 | Intellis Adaptivestim |
| Surgenex LLC | $20.63 | 2025 | Surgraft, Surmatrix, Pellograft |
| Treace Medical Concepts, INC. | $19.53 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.62 | 2023 | Jublia |
| Osteocentric Technologies, INC. | $13.40 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Integra Lifesciences Corporation | $12.20 | 2019 | |
| Polynovo North America LLC | $8.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Husain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.